T1	Age 2 13	35-year-old
T2	Sex 14 19	woman
T3	Duration 40 45	5-day
E1	Duration:T3 
T4	Clinical_event 24 32	admitted
E2	Clinical_event:T4 
T5	Sign_symptom 68 78	drowsiness
E3	Sign_symptom:T5 
A1	TREND E3 INC
T6	Sign_symptom 80 87	fatigue
E4	Sign_symptom:T6 
A2	TREND E4 INC
T7	Sign_symptom 89 108	personality changes
E5	Sign_symptom:T7 
A3	TREND E5 INC
T8	Sign_symptom 122 130	weakness
E6	Sign_symptom:T8 
A4	TREND E6 INC
T9	Detailed_description 110 121	generalised
R1	MODIFY Arg1:T9 Arg2:E6	
T10	Diagnostic_procedure 149 157	mobility
E7	Diagnostic_procedure:T10 
T11	Qualitative_concept 135 148	deteriorating
R2	MODIFY Arg1:T11 Arg2:E7	
T12	History 190 234	10-year history of schizo-affective disorder
T13	History 236 270	lithium-induced diabetes insipidus
T14	History 275 289	hypothyroidism
T15	Duration 190 197	10-year
E8	Duration:T15 
T16	Disease_disorder 209 234	schizo-affective disorder
E9	Disease_disorder:T16 
T17	Disease_disorder 252 270	diabetes insipidus
E10	Disease_disorder:T17 
T18	Detailed_description 236 251	lithium-induced
R3	MODIFY Arg1:T18 Arg2:E10	
T19	Disease_disorder 275 289	hypothyroidism
E11	Disease_disorder:T19 
T20	Medication 316 332	sodium valproate
E12	Medication:T20 
T21	Dosage 333 348	1 g twice daily
R4	MODIFY Arg1:T21 Arg2:E12	
T22	Medication 350 363	carbamazepine
E13	Medication:T22 
T23	Medication 365 375	quetiapine
E14	Medication:T23 
T24	Medication 380 387	lithium
E15	Medication:T24 
T25	Sign_symptom 419 425	drowsy
E16	Sign_symptom:T25 
T26	Sign_symptom 427 445	difficult to rouse
E17	Sign_symptom:T26 
T27	Activity 447 455	sleeping
E18	Activity:T27 
T28	Detailed_description 456 486	all night and in the afternoon
R5	MODIFY Arg1:T28 Arg2:E18	
T29	Activity 392 401	admission
E19	Activity:T29 
T30	Diagnostic_procedure 493 511	Glasgow Coma Scale
E20	Diagnostic_procedure:T30 
T31	Diagnostic_procedure 513 516	GCS
E21	Diagnostic_procedure:T31 
R6	IDENTICAL Arg1:E21 Arg2:E20	
T32	Quantitative_concept 522 527	14/15
R7	MODIFY Arg1:T32 Arg2:E20	
T33	Diagnostic_procedure 545 567	mini-mental test score
E22	Diagnostic_procedure:T33 
T34	Quantitative_concept 572 576	6/10
R8	MODIFY Arg1:T34 Arg2:E22	
T35	Qualitative_concept 601 605	slow
R9	MODIFY Arg1:T35 Arg2:E22	
T36	Diagnostic_procedure 624 648	Neurological examination
E23	Diagnostic_procedure:T36 
T37	Diagnostic_procedure 835 847	examinations
E24	Diagnostic_procedure:T37 
T38	Biological_structure 818 834	gastrointestinal
T39	Biological_structure 802 813	respiratory
T40	Biological_structure 786 800	Cardiovascular
R10	MODIFY Arg1:T38 Arg2:E24	
R11	MODIFY Arg1:T39 Arg2:E24	
R12	MODIFY Arg1:T40 Arg2:E24	
T42	Disease_disorder 909 924	hepatic disease
E25	Disease_disorder:T42 
A5	POLARITY E25 NEG
T43	Diagnostic_procedure 934 946	biochemistry
E26	Diagnostic_procedure:T43 
T44	Qualitative_concept 951 963	unremarkable
R14	MODIFY Arg1:T44 Arg2:E26	
T45	Detailed_description 926 933	Routine
R15	MODIFY Arg1:T45 Arg2:E26	
T46	Diagnostic_procedure 1147 1150	B12
E27	Diagnostic_procedure:T46 
T47	Diagnostic_procedure 1155 1161	folate
E28	Diagnostic_procedure:T47 
T48	Detailed_description 1141 1146	serum
R16	MODIFY Arg1:T48 Arg2:E27	
R17	MODIFY Arg1:T48 Arg2:E28	
T49	Qualitative_concept 1134 1140	normal
R18	MODIFY Arg1:T49 Arg2:E27	
R19	MODIFY Arg1:T49 Arg2:E28	
T50	Diagnostic_procedure 979 999	alanine transaminase
E29	Diagnostic_procedure:T50 
T51	Lab_value 1004 1009	7 u/L
R20	MODIFY Arg1:T51 Arg2:E29	
T52	Diagnostic_procedure 1018 1038	alkaline phosphatase
E30	Diagnostic_procedure:T52 
T53	Lab_value 1039 1045	61 u/L
R21	MODIFY Arg1:T53 Arg2:E30	
T54	Diagnostic_procedure 1056 1078	γ-glutamyl transferase
E31	Diagnostic_procedure:T54 
T55	Lab_value 1079 1085	17 u/L
R22	MODIFY Arg1:T55 Arg2:E31	
T56	Diagnostic_procedure 1096 1105	bilirubin
E32	Diagnostic_procedure:T56 
T57	Lab_value 1110 1118	6 μmol/L
R23	MODIFY Arg1:T57 Arg2:E32	
T58	Diagnostic_procedure 1211 1218	lithium
E33	Diagnostic_procedure:T58 
T59	Qualitative_concept 1231 1259	within the therapeutic range
R24	MODIFY Arg1:T59 Arg2:E33	
T60	Detailed_description 1205 1210	Serum
R25	MODIFY Arg1:T60 Arg2:E33	
T61	Diagnostic_procedure 1181 1203	thyroid function tests
E34	Diagnostic_procedure:T61 
T62	Qualitative_concept 1174 1180	normal
R26	MODIFY Arg1:T62 Arg2:E34	
T63	Diagnostic_procedure 1271 1278	ammonia
E35	Diagnostic_procedure:T63 
T64	Diagnostic_procedure 664 669	power
E36	Diagnostic_procedure:T64 
T65	Qualitative_concept 656 663	reduced
R27	MODIFY Arg1:T65 Arg2:E36	
T66	Biological_structure 677 688	lower limbs
R28	MODIFY Arg1:T66 Arg2:E36	
T67	Quantitative_concept 690 695	3–4/5
R29	MODIFY Arg1:T67 Arg2:E36	
T68	Qualitative_concept 702 724	pyramidal distribution
R30	MODIFY Arg1:T68 Arg2:E36	
T69	Diagnostic_procedure 736 744	reflexes
E37	Diagnostic_procedure:T69 
T70	Diagnostic_procedure 757 766	sensation
E38	Diagnostic_procedure:T70 
T71	Qualitative_concept 730 735	brisk
R31	MODIFY Arg1:T71 Arg2:E37	
T72	Qualitative_concept 750 756	intact
R32	MODIFY Arg1:T72 Arg2:E38	
T73	Detailed_description 770 784	all modalities
R33	MODIFY Arg1:T73 Arg2:E38	
R34	SUB_PROCEDURE Arg1:E36 Arg2:E23	
R35	SUB_PROCEDURE Arg1:E37 Arg2:E23	
R36	SUB_PROCEDURE Arg1:E38 Arg2:E23	
T74	Lab_value 1283 1292	47 μmol/L
R37	MODIFY Arg1:T74 Arg2:E35	
T75	Diagnostic_procedure 1309 1318	valproate
E39	Diagnostic_procedure:T75 
T76	Qualitative_concept 1339 1347	elevated
R38	MODIFY Arg1:T76 Arg2:E39	
T77	Lab_value 1348 1356	140 mg/L
R39	MODIFY Arg1:T77 Arg2:E39	
T78	Disease_disorder 1708 1720	encephalitis
E40	Disease_disorder:T78 
A6	POLARITY E40 NEG
T79	Disease_disorder 1722 1745	Guillain-Barré syndrome
E41	Disease_disorder:T79 
A7	POLARITY E41 NEG
T80	Disease_disorder 1750 1786	acute disseminated encephalomyelitis
E42	Disease_disorder:T80 
A8	POLARITY E42 NEG
T81	Disease_disorder 1788 1792	ADEM
E43	Disease_disorder:T81 
R40	IDENTICAL Arg1:E43 Arg2:E42	
T82	Disease_disorder 1910 1950	valproate hyperammonaemic encephalopathy
E44	Disease_disorder:T82 
T83	Disease_disorder 1952 1955	VHE
E45	Disease_disorder:T83 
R41	IDENTICAL Arg1:E45 Arg2:E44	
T84	Diagnostic_procedure 1565 1568	EEG
E46	Diagnostic_procedure:T84 
T85	Diagnostic_procedure 1453 1468	Lumbar puncture
E47	Diagnostic_procedure:T85 
T86	Qualitative_concept 1482 1487	clear
T87	Biological_structure 1488 1507	cerebrospinal fluid
R42	MODIFY Arg1:T87 Arg2:T86	
R43	MODIFY Arg1:T86 Arg2:E47	
T88	Diagnostic_procedure 1509 1525	white cell count
E48	Diagnostic_procedure:T88 
T89	Diagnostic_procedure 1536 1543	protein
E49	Diagnostic_procedure:T89 
T90	Quantitative_concept 1526 1534	<1×106/L
T91	Lab_value 1544 1552	0.25 g/L
R44	MODIFY Arg1:T91 Arg2:E49	
R45	MODIFY Arg1:T90 Arg2:E48	
R46	SUB_PROCEDURE Arg1:E48 Arg2:E47	
R47	SUB_PROCEDURE Arg1:E49 Arg2:E47	
T92	Diagnostic_procedure 1865 1874	valproate
E50	Diagnostic_procedure:T92 
T93	Diagnostic_procedure 1879 1886	ammonia
E51	Diagnostic_procedure:T93 
T94	Lab_value 1858 1864	raised
E52	Lab_value:T94 
R48	MODIFY Arg1:E52 Arg2:E50	
R49	MODIFY Arg1:E52 Arg2:E51	
T95	Medication 1992 2008	sodium valproate
E53	Medication:T95 
T96	Dosage 2013 2028	reduced by half
R50	MODIFY Arg1:T96 Arg2:E53	
T97	Disease_disorder 2146 2171	schizo-affective disorder
E54	Disease_disorder:T97 
T98	Lab_value 2215 2226	improvement
E55	Lab_value:T98 
T99	Diagnostic_procedure 2234 2247	mental status
E56	Diagnostic_procedure:T99 
R51	MODIFY Arg1:E55 Arg2:E56	
T100	Date 2173 2186	Within 3 days
E57	Date:T100 
T101	Activity 2273 2276	sit
E58	Activity:T101 
T102	Activity 2281 2292	communicate
E59	Activity:T102 
T103	Diagnostic_procedure 2316 2345	abbreviated mental test score
E60	Diagnostic_procedure:T103 
T104	Lab_value 2346 2354	improved
E61	Lab_value:T104 
T105	Lab_value 2358 2363	10/10
E62	Lab_value:T105 
R52	MODIFY Arg1:E61 Arg2:E60	
R53	MODIFY Arg1:E62 Arg2:E60	
T106	Date 2450 2462	After 4 days
E63	Date:T106 
T107	Clinical_event 2471 2481	discharged
E64	Clinical_event:T107 
T108	Nonbiological_location 2482 2486	home
R54	MODIFY Arg1:T108 Arg2:E64	
T109	Sign_symptom 1596 1603	slowing
E65	Sign_symptom:T109 
T110	Sign_symptom 1608 1643	irregularity of background activity
E66	Sign_symptom:T110 
T111	Severity 1582 1586	mild
R55	MODIFY Arg1:T111 Arg2:E65	
T112	Diagnostic_procedure 1391 1393	CT
E67	Diagnostic_procedure:T112 
T113	Diagnostic_procedure 1373 1380	imaging
E68	Diagnostic_procedure:T113 
T114	Biological_structure 1367 1372	Brain
R56	MODIFY Arg1:T114 Arg2:E68	
T115	Detailed_description 1265 1270	serum
R57	MODIFY Arg1:T115 Arg2:E35	
T116	Diagnostic_procedure 1398 1401	MRI
E69	Diagnostic_procedure:T116 
T117	Sign_symptom 1419 1430	haemorrhage
E70	Sign_symptom:T117 
A9	POLARITY E70 NEG
T118	Sign_symptom 1447 1451	mass
E71	Sign_symptom:T118 
A10	POLARITY E71 NEG
T119	Biological_structure 1434 1446	intracranial
R58	MODIFY Arg1:T119 Arg2:E71	
T120	Diagnostic_procedure 2374 2381	ammonia
E72	Diagnostic_procedure:T120 
T121	Lab_value 2382 2392	normalised
E73	Lab_value:T121 
T122	Detailed_description 2368 2373	serum
T123	Medication 1309 1318	valproate
E74	Medication:T123 
R59	MODIFY Arg1:T122 Arg2:E72	
R60	MODIFY Arg1:E73 Arg2:E72	
T124	Diagnostic_procedure 2397 2406	valproate
E75	Diagnostic_procedure:T124 
T125	Medication 2397 2406	valproate
E76	Medication:T125 
T126	Lab_value 2414 2423	decreased
E77	Lab_value:T126 
R61	MODIFY Arg1:E77 Arg2:E75	
T127	Lab_value 2431 2448	therapeutic range
E78	Lab_value:T127 
R62	MODIFY Arg1:E78 Arg2:E75	
T128	Diagnostic_procedure 2499 2513	investigations
E79	Diagnostic_procedure:T128 
T129	Detailed_description 2521 2531	urea cycle
R63	MODIFY Arg1:T129 Arg2:E79	
T131	Date 2546 2557	Three weeks
E81	Date:T131 
T132	Clinical_event 2562 2571	discharge
E82	Clinical_event:T132 
T130	Diagnostic_procedure 2619 2637	mental functioning
E80	Diagnostic_procedure:T130 
T133	Lab_value 2600 2606	stable
E83	Lab_value:T133 
R64	MODIFY Arg1:E83 Arg2:E80	
T134	Sign_symptom 2673 2682	confusion
E84	Sign_symptom:T134 
A11	POLARITY E84 NEG
T135	Sign_symptom 2686 2696	drowsiness
E85	Sign_symptom:T135 
A12	POLARITY E85 NEG
T136	Sign_symptom 2729 2736	fatigue
E86	Sign_symptom:T136 
T137	Sign_symptom 2741 2761	walking difficulties
E87	Sign_symptom:T137 
T138	Sign_symptom 2783 2791	weakness
E88	Sign_symptom:T138 
T139	Biological_structure 2779 2782	leg
R65	MODIFY Arg1:T139 Arg2:E88	
T140	Detailed_description 2770 2778	residual
R66	MODIFY Arg1:T140 Arg2:E88	
T141	Diagnostic_procedure 2815 2826	amino acids
E89	Diagnostic_procedure:T141 
T142	Detailed_description 2809 2814	serum
R67	MODIFY Arg1:T142 Arg2:E89	
T143	Disease_disorder 2857 2877	carnitine deficiency
E90	Disease_disorder:T143 
T144	Diagnostic_procedure 2893 2907	acyl-carnitine
E91	Diagnostic_procedure:T144 
T145	Lab_value 2889 2892	low
E92	Lab_value:T145 
R68	MODIFY Arg1:E92 Arg2:E91	
T146	Diagnostic_procedure 2924 2933	carnitine
E93	Diagnostic_procedure:T146 
T147	Detailed_description 2918 2923	serum
T148	Detailed_description 2913 2917	free
R69	MODIFY Arg1:T147 Arg2:E93	
R70	MODIFY Arg1:T148 Arg2:E93	
T149	Lab_value 2909 2912	low
E94	Lab_value:T149 
R71	MODIFY Arg1:E94 Arg2:E93	
T150	Lab_value 2935 2946	14.2 μmol/L
E95	Lab_value:T150 
R72	MODIFY Arg1:E95 Arg2:E93	
T151	Diagnostic_procedure 2989 2998	carnitine
E96	Diagnostic_procedure:T151 
T152	Detailed_description 2977 2982	total
T153	Detailed_description 2983 2988	serum
R73	MODIFY Arg1:T153 Arg2:E96	
R74	MODIFY Arg1:T152 Arg2:E96	
T154	Lab_value 2973 2976	low
E97	Lab_value:T154 
R75	MODIFY Arg1:E97 Arg2:E96	
T155	Lab_value 3000 3011	19.9 μmol/L
E98	Lab_value:T155 
R76	MODIFY Arg1:E98 Arg2:E96	
T156	Medication 3059 3068	carnitine
E99	Medication:T156 
T157	Administration 3054 3058	oral
R77	MODIFY Arg1:T157 Arg2:E99	
T158	Dosage 3069 3084	1 g twice daily
R78	MODIFY Arg1:T158 Arg2:E99	
T159	Date 3086 3100	Within 2 weeks
E100	Date:T159 
T160	Sign_symptom 3106 3114	symptoms
E101	Sign_symptom:T160 
A13	POLARITY E101 NEG
T161	Diagnostic_procedure 3163 3172	carnitine
E102	Diagnostic_procedure:T161 
T162	Detailed_description 3157 3162	serum
R79	MODIFY Arg1:T162 Arg2:E102	
T163	Lab_value 3140 3153	normalisation
E103	Lab_value:T163 
R80	MODIFY Arg1:E103 Arg2:E102	
T164	Diagnostic_procedure 3186 3195	carnitine
E104	Diagnostic_procedure:T164 
T165	Diagnostic_procedure 3218 3227	carnitine
E105	Diagnostic_procedure:T165 
T166	Detailed_description 3212 3217	total
T167	Detailed_description 3181 3185	free
R81	MODIFY Arg1:T167 Arg2:E104	
R82	MODIFY Arg1:T166 Arg2:E105	
T168	Lab_value 3231 3242	41.3 μmol/L
E106	Lab_value:T168 
T169	Lab_value 3196 3207	25.2 μmol/L
E107	Lab_value:T169 
R83	MODIFY Arg1:E107 Arg2:E104	
R84	MODIFY Arg1:E106 Arg2:E105	
R85	SUB_PROCEDURE Arg1:E104 Arg2:E102	
R86	SUB_PROCEDURE Arg1:E105 Arg2:E102	
T170	Medication 3249 3265	sodium valproate
E108	Medication:T170 
A14	POLARITY E108 NEG
T171	Disease_disorder 3346 3371	schizo-affective disorder
E109	Disease_disorder:T171 
T172	Detailed_description 3321 3328	relapse
R87	MODIFY Arg1:T172 Arg2:E109	
T173	Medication 3413 3422	valproate
E110	Medication:T173 
T174	Dosage 3423 3437	1 g once daily
R88	MODIFY Arg1:T174 Arg2:E110	
T175	Medication 3452 3473	carnitine supplements
E111	Medication:T175 
T176	Detailed_description 3442 3451	long-term
R89	MODIFY Arg1:T176 Arg2:E111	
T177	Sign_symptom 3405 3409	well
E112	Sign_symptom:T177 
R90	AFTER Arg1:E2 Arg2:E1	
*	OVERLAP E1 E3 E4 E5 E6 E7
R91	AFTER Arg1:E7 Arg2:E8	
*	OVERLAP E8 E9 E10 E11
R92	BEFORE Arg1:E11 Arg2:E12	
*	OVERLAP E12 E13 E14 E15
R93	BEFORE Arg1:E15 Arg2:E19	
*	OVERLAP E19 E16 E17 E18 E20 E22 E23 E24 E25 E26 E29 E30 E31 E32 E27 E28 E34 E33 E35 E74 E39 E68 E70 E71 E47 E46 E65 E66 E114
T41	Lab_value 853 865	unremarkable
E113	Lab_value:T41 
R13	MODIFY Arg1:E113 Arg2:E24	
R94	SUB_PROCEDURE Arg1:E67 Arg2:E68	
R95	SUB_PROCEDURE Arg1:E69 Arg2:E68	
T178	Medication 1659 1669	medication
E114	Medication:T178 
R96	BEFORE Arg1:E114 Arg2:E40	
*	OVERLAP E40 E41 E42 E50 E51 E44
R97	BEFORE Arg1:E44 Arg2:E53	
*	OVERLAP E53 E54
R98	BEFORE Arg1:E54 Arg2:E57	
*	OVERLAP E57 E56 E58 E59 E60 E72 E75 E76
R99	BEFORE Arg1:E76 Arg2:E63	
*	OVERLAP E63 E64
R100	BEFORE Arg1:E64 Arg2:E79	
R101	BEFORE Arg1:E79 Arg2:E81	
R102	AFTER Arg1:E81 Arg2:E82	
R103	BEFORE Arg1:E82 Arg2:E80	
*	OVERLAP E80 E84 E85 E86 E87 E88
R104	BEFORE Arg1:E88 Arg2:E89	
*	OVERLAP E89 E90 E91 E93 E96
R105	BEFORE Arg1:E96 Arg2:E99	
R106	BEFORE Arg1:E99 Arg2:E100	
*	OVERLAP E100 E101 E102
R107	BEFORE Arg1:E102 Arg2:E108	
R108	BEFORE Arg1:E108 Arg2:E109	
R109	BEFORE Arg1:E109 Arg2:E112	
*	OVERLAP E112 E110 E111
